Potential antiviral properties of antifungal drugs

Potential antiviral properties of antifungal drugs

Bibliographic Details
Main Authors:	Falah H.O Al-Khikani, Huda A.S Almosawey, Younus J Abdullah, Atyaf A Al-Asadi, Raghdah M Hameed, Noor F Hasan, Mohanad K.M Al-Ibraheemi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Journal of the Egyptian Women’s Dermatologic Society
Subjects:	corona virus covid-19 itraconazole posaconazole
Online Access:	http://www.jewd.eg.net//article.asp?issn=1687-1537;year=2020;volume=17;issue=3;spage=185;epage=186;aulast=Al-Khikani

Similar Items

Evaluation of the role of itraconazole and posaconazole in viral infection as immunomodulatory drugs
by: Falah Hasan Obayes AL-Khikani
Published: (2021-01-01)

Phaeohyphomycosis in Transplant Patients
by: Sanjay G. Revankar
Published: (2015-12-01)

Antifungal susceptibility patterns of colonized Candida species isolates from immunocompromised pediatric patients in five university hospitals
by: Parisa Badiee, et al.
Published: (2018-01-01)

Tamoxifen from chemotherapy to antiviral drug: Possible activity against COVID-19
by: Huda Ali Salman Almosawey, et al.
Published: (2020-01-01)

Immunological prospects of tamoxifen as modern antiviral therapy
by: Falah AL-Khikani, et al.
Published: (2020-01-01)

INK128 exhibits synergy with azoles against Exophiala spp. and Fusarium spp.
by: Lujuan Gao, et al.
Published: (2016-10-01)

Conazoles
by: Jan Heeres, et al.
Published: (2010-06-01)

Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis
by: Fazal Shirazi, et al.
Published: (2014-06-01)

The possible role of immunoglobulin A monoclonal antibodies against COVID-19 infection
by: Raghdah Maytham Hameed, et al.
Published: (2020-01-01)

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
by: Döring Michaela, et al.
Published: (2012-10-01)

MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method
by: Andrew M. Borman, et al.
Published: (2017-05-01)

Amphotericin B from antifungal to antiviral therapy: promising modern therapeutic branch
by: Falah Hasan Obayes AL-Khikani
Published: (2020-06-01)

In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
by: Mohammad Aamir Mirza, et al.
Published: (2012-12-01)

Use of antifungals in pediatric superficial dermatophytosis
by: Grishma R Gandhi, et al.
Published: (2020-01-01)

Antifungal susceptibility testing of vaginal candida isolates: the broth microdilution method
by: Mahmoudi Rad M, et al.
Published: (2010-02-01)

In vitro Resistance Pattern of Selected Antifungal Azoles against Candida albicans Biofilms on Silicone Nasogastric Tube
by: Derick Erl P. Sumalapao, et al.
Published: (2019-12-01)

A study to compare efficacy of various oral antifungals (Fluconazole, Terbinafine, Itraconazole) in treatment of Onychomycosis
by: Deval N Vora, et al.
Published: (2014-12-01)

Sinus bradycardia and chronotropic incompetence associated with single-agent itraconazole antifungal therapy: A case report
by: Julian Tokarev, BS, et al.
Published: (2015-01-01)

Patterns of culture positivity and antifungal sensitivity in dermatophytosis
by: Vedant Ghuse, et al.
Published: (2019-01-01)

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
by: Stefan Hatzl, et al.
Published: (2021-09-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-02-01)

Mucor menace in an immunocompetent young male after dental manipulation
by: Nitin Gupta, et al.
Published: (2019-01-01)

Determination of Posaconazole in Plasma/Serum by High-Performance Liquid Chromatography with Fluorescence Detection
by: Peter H. Tang
Published: (2017-05-01)

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis Tratamento com posaconazol de casos de cromoblastomicose e micetoma maduromicótico resistentes a outros antifúngicos
by: Ricardo Negroni, et al.
Published: (2005-12-01)

Comparison of Characteristics of Patients who Received Posaconazole or Voriconazole for the Treatment of Coccidioidomycosis
by: Hackman, Christine, et al.
Published: (2013)

March 2014 Arizona thoracic society notes
by: Robbins RA
Published: (2014-04-01)

Sensitivity of antifungal preparations of Сandida isolates from sub-biotopes of the human oral cavity
by: N. О. Osypchuk, et al.
Published: (2020-02-01)

The role of antifungals in the management of patients with severe asthma
by: W. Garth Rapeport, et al.
Published: (2020-11-01)

In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles
by: Andrew M. Borman, et al.
Published: (2021-04-01)

Paecilomyces Pneumonia Despite Voriconazole Prophylaxis: A Case Report and Literature Review
by: Abuzar A Asif, et al.
Published: (2021-06-01)

Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study
by: Agarwal Pankaj, et al.
Published: (2001-01-01)

Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar
by: Khan M, et al.
Published: (2018-03-01)

Be conscious to be healthy: An initiative to prevent recurrent urinary tract infection in Iraqi women
by: Falah Hasan Obayes AL Khikani, et al.
Published: (2020-01-01)

Morphological changes and induction of antifungal resistance in Aspergillus fumigatus due to different CO2 levels
by: Sima Darabian, et al.
Published: (2017-09-01)

In silico drug repurposing: An antifungal drug, itraconazole, repurposed as an anticancer agent using molecular docking
by: Sanika Dhorje, et al.
Published: (2020-01-01)

UV Spectrophotometric method for determination of posaconazole: comparison to HPLC
by: Andressa S. Bitencourt, et al.
Published: (2015-10-01)

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
by: Edward T. Van Matre, et al.
Published: (2019-03-01)

Disseminated pulmonary mucormycosis with concomitant tuberculosis infection in a diabetic patient
by: Priyamvadha Ramesh, et al.
Published: (2020-01-01)

How should we manage a patient with invasive mucoromycosis who develops life-threatening reaction to amphotericin B? Report of two cases and literature review
by: Fereshte Sheybani, et al.
Published: (2015-06-01)